STERIS Common Stock Net 2010-2025 | STE
STERIS common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
- STERIS common stock net for the quarter ending March 31, 2025 was $4.420B, a 2.7% decline year-over-year.
- STERIS common stock net for 2025 was $4.42B, a 2.7% decline from 2024.
- STERIS common stock net for 2024 was $4.543B, a 1.27% increase from 2023.
- STERIS common stock net for 2023 was $4.486B, a 5.41% decline from 2022.
| STERIS Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2025 | $4,420 |
| 2024 | $4,543 |
| 2023 | $4,486 |
| 2022 | $4,743 |
| 2021 | $2,003 |
| 2020 | $1,982 |
| 2019 | $1,999 |
| 2018 | $2,048 |
| 2017 | $2,085 |
| 2016 | $2,152 |
| 2015 | $265 |
| 2014 | $246 |
| 2013 | $240 |
| 2012 | $244 |
| 2011 | $241 |
| 2010 | $237 |
| 2009 | $232 |
| STERIS Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $4,420 |
| 2024-12-31 | $4,405 |
| 2024-09-30 | $4,491 |
| 2024-06-30 | $4,500 |
| 2024-03-31 | $4,543 |
| 2023-12-31 | $4,534 |
| 2023-09-30 | $4,519 |
| 2023-06-30 | $4,498 |
| 2023-03-31 | $4,486 |
| 2022-12-31 | $4,632 |
| 2022-09-30 | $4,705 |
| 2022-06-30 | $4,739 |
| 2022-03-31 | $4,743 |
| 2021-12-31 | $4,758 |
| 2021-09-30 | $4,748 |
| 2021-06-30 | $4,737 |
| 2021-03-31 | $2,003 |
| 2020-12-31 | $1,997 |
| 2020-09-30 | $1,991 |
| 2020-06-30 | $1,983 |
| 2020-03-31 | $1,982 |
| 2019-12-31 | $1,987 |
| 2019-09-30 | $1,982 |
| 2019-06-30 | $1,996 |
| 2019-03-31 | $1,999 |
| 2018-12-31 | $2,018 |
| 2018-09-30 | $2,013 |
| 2018-06-30 | $2,027 |
| 2018-03-31 | $2,048 |
| 2017-12-31 | $2,064 |
| 2017-09-30 | $2,081 |
| 2017-06-30 | $2,087 |
| 2017-03-31 | $2,085 |
| 2016-12-31 | $2,083 |
| 2016-09-30 | $2,113 |
| 2016-06-30 | $2,161 |
| 2016-03-31 | $2,152 |
| 2015-12-31 | $1,847 |
| 2015-09-30 | $272 |
| 2015-06-30 | $268 |
| 2015-03-31 | $265 |
| 2014-12-31 | $258 |
| 2014-09-30 | $250 |
| 2014-06-30 | $246 |
| 2014-03-31 | $246 |
| 2013-12-31 | $244 |
| 2013-09-30 | $241 |
| 2013-06-30 | $238 |
| 2013-03-31 | $240 |
| 2012-12-31 | $241 |
| 2012-09-30 | $242 |
| 2012-06-30 | $239 |
| 2012-03-31 | $244 |
| 2011-12-31 | $242 |
| 2011-09-30 | $243 |
| 2011-06-30 | $238 |
| 2011-03-31 | $241 |
| 2010-12-31 | $240 |
| 2010-09-30 | $238 |
| 2010-06-30 | $236 |
| 2010-03-31 | $237 |
| 2009-12-31 | $236 |
| 2009-09-30 | $232 |
| 2009-06-30 | $232 |
| 2009-03-31 | $232 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $23.490B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $191.291B | 83.79 |
| Thermo Fisher Scientific (TMO) | United States | $154.123B | 18.64 |
| Edwards Lifesciences (EW) | United States | $45.878B | 30.08 |
| Alcon (ALC) | Switzerland | $43.312B | 29.27 |
| IDEXX Laboratories (IDXX) | United States | $42.730B | 49.10 |
| DexCom (DXCM) | United States | $33.851B | 52.32 |
| IQVIA Holdings (IQV) | United States | $27.242B | 15.26 |
| Mettler-Toledo (MTD) | United States | $24.618B | 29.28 |
| Waters (WAT) | United States | $20.972B | 29.59 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.819B | 0.00 |
| Hologic (HOLX) | United States | $14.487B | 15.74 |
| Sysmex ADR (SSMXY) | Japan | $10.827B | 30.71 |
| Penumbra (PEN) | United States | $9.930B | 77.94 |
| Masimo (MASI) | United States | $9.120B | 33.64 |
| Globus Medical (GMED) | United States | $7.933B | 18.90 |
| Glaukos (GKOS) | United States | $5.795B | 0.00 |
| Teleflex (TFX) | United States | $5.279B | 8.71 |
| TransMedics (TMDX) | United States | $4.446B | 96.65 |
| Integer Holdings (ITGR) | United States | $4.276B | 22.41 |
| PROCEPT BioRobotics (PRCT) | United States | $3.149B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.495B | 14.85 |
| Veracyte (VCYT) | United States | $2.144B | 30.09 |
| Nihon Kohden (NHNKY) | Japan | $2.041B | 23.41 |
| Elekta AB (EKTAY) | Sweden | $1.933B | 17.38 |
| Alphatec Holdings (ATEC) | United States | $1.620B | 0.00 |
| Artivion (AORT) | United States | $1.332B | 124.76 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.014B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.955B | 5.08 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| IRadimed (IRMD) | United States | $0.774B | 39.25 |
| Beta Bionics (BBNX) | United States | $0.653B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.565B | 8.78 |
| Mesa Laboratories (MLAB) | United States | $0.538B | 12.62 |
| OrthoPediatrics (KIDS) | United States | $0.519B | 0.00 |
| RxSight (RXST) | United States | $0.515B | 0.00 |
| AxoGen (AXGN) | United States | $0.478B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.473B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.429B | 11.42 |
| AngioDynamics (ANGO) | United States | $0.397B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| NeuroPace (NPCE) | United States | $0.351B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.330B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.241B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.56 |
| Neuronetics (STIM) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.222B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.209B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.157B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.150B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.146B | 0.00 |
| Accuray (ARAY) | United States | $0.142B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.60 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |